发明公开
- 专利标题： HEPATITIS C VIRUS INHIBITORS
- 专利标题（中）： 丙型肝炎病毒抑制剂
-
申请号： EP10779401.8申请日： 2010-11-10
-
公开(公告)号： EP2499132A1公开(公告)日： 2012-09-19
- 发明人: LAVOIE, Rico , BENDER, John A. , ROMINE, Jeffrey Lee , RUEDIGER, Edward H. , BACHAND, Carol , LOPEZ, Omar D. , CHEN, Qi , BELEMA, Makonen , KADOW, John F. , HAMANN, Lawrence G.
- 申请人： Bristol-Myers Squibb Company
- 申请人地址： Route 206 and Province Line Road Princeton, NJ 05843-4000 US
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： Route 206 and Province Line Road Princeton, NJ 05843-4000 US
- 代理机构： Riedl, Peter
- 优先权： US260569P 20091112; US942183 20101109
- 国际公布： WO2011060000 20110519
- 主分类号： C07D403/06
- IPC分类号： C07D403/06 ; C07D403/10 ; C07D417/10 ; C07D419/10 ; C07D417/02 ; C07D419/02 ; A61K31/4178
摘要：
This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
公开/授权文献
- EP2499132B1 HEPATITIS C VIRUS INHIBITORS 公开/授权日：2017-02-15
信息查询
